ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,874.18
-0.31%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Mereo BioPharma Group PLC (MREO)

  7. Mereo BioPharma Group PLC (MREO) ニュース

MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MREO
日付受信時刻ニュースソース見出しコード企業名
2024/05/1605 : 49Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605 : 19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605 : 01GlobeNewswire Inc.Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
2024/04/0320 : 30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
2024/03/2805 : 01GlobeNewswire Inc.Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
2024/03/0521 : 30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/0706 : 15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
2024/01/2706 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/2706 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/2406 : 16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0821 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0821 : 00GlobeNewswire Inc.Mereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2023/12/1906 : 16Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
2023/12/1906 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/11/3006 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/11/1621 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/10/2405 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/10/2405 : 01GlobeNewswire Inc.Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateNASDAQ:MREOMereo BioPharma Group PLC
 Showing the most relevant articles for your search:NASDAQ:MREO

最近閲覧した銘柄

LSE
HSVR
NASDAQ
IHYF
Invesco High Yield Bond ...
LSE
98LM
Turkiye Gdr 4a
COIN
MNTGBP
LBNK
WEXUSDT
WaultSwap
UNSW3
MINDSETH
Minds
POLO
ARDRUSDT
Ardor
ASX
1VG
Victory Goldfields
NASDAQ
FCLF
AQSE
GBCH.GB
WisdomTree Commodity Sec...
AMEX
GQN
AMEX
EFAX
SPDR MSCI Eafe Fossil Fu...
LSE
RG28
Sw.fin.a8
USOTC
AAQCW
BOV
VALE-DEB82L1
VALE
NASDAQ
LEGR
First Trust Indxx Innova...
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有